Table 1 |
|||
|
Characteristics and baseline outcome of the subjects at baseline |
|||
|
PG (n = 15) |
SG (n = 15) |
P-value |
|
|
|
|||
|
Age (yr) |
50.3 ± 5.6 (39-58) |
49.3 ± 7.7 (38-59) |
0.70 |
|
Height (cm) |
161.4 ± 5.4 (154-171) |
159.5 ± 7.5 (150-173) |
0.45 |
|
BW (kg) |
66.9 ± 8.7 (53.9-78.5) |
68.1 ± 12.1 (57.5-92.7) |
0.71 |
|
BMI (kg/m2) |
25.6 ± 2.4 (21.8-29.1) |
26.6 ± 3.2 (22.7-34.3) |
0.29 |
|
%BF |
31.5 ± 4.6 (24.7-37.6) |
31.6 ± 3.4 (26.7-37.2) |
0.92 |
|
FM (kg) |
21.3 ± 5.1 (13.3-28.5) |
21.7 ± 5.2 (15.9-32.7) |
0.81 |
|
FFM (kg) |
45.6 ± 4.7 (37.6-52.9) |
46.4 ± 7.6 (37.7-60.9) |
0.69 |
|
W (cm) |
84.6 ± 6.9 (72-94) |
85.8 ± 9.6 (74.5-107) |
0.66 |
|
H (cm) |
95.3 ± 4.9 (86-101.5) |
96.9 ± 5.4 (88-108) |
0.35 |
|
W/H ratio |
0.89 ± 0.1 (0.77-0.94) |
0.88 ± 0.1 (0.79-1.02) |
0.75 |
|
MDA (μmol/L) |
1.9 ± 0.62 (0.86-2.78) |
1.8 ± 0.6 (1.19-2.81) |
0.67 |
|
Vitamin E (μmol/L) |
26.5 ± 5.5 (17.2-34.4) |
29.4 ± 6.0 (19.1-45.8) |
0.18 |
|
SBP (mmHg) |
130.4 ± 4.8 (127-138) |
129.3 ± 6.8 (121-137) |
0.43 |
|
DBP (mmHg) |
80.6 ± 7.7 (72-99) |
77.0 ± 7.4 (65-87) |
0.63 |
|
MAP (mmHg) |
97.2 ± 4.7 (90.3-108.7) |
94.4 ± 6.1 (84.7-103.7) |
0.51 |
|
HR (/min) |
66.8 ± 7.4 (59-85) |
68.7 ± 9.1 (53-93) |
0.61 |
|
|
|||
|
Values are expressed as means ± SD (minimum-maximum). PG, placebo group; SG, black sesame meal group; BW, body weight; BMI, body mass index; %BF, percentage of body fat; FM, fat mass; FFM, fat-free mass; W, waist circumference; H, hip circumference; W/H ratio, waist and hip circumference ratio; MDA, malondialdehyde; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate |
|||
|
Wichitsranoi et al. Nutrition Journal 2011 10:82 doi:10.1186/1475-2891-10-82 |
|||
